The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
When The Boss Is In, Everyone Plays Nice: Study
Concern over a person's reputation in the eyes of an authority figure, like a village elder, may encourage cooperation with others, a study shows.
Putting The Pressure On Platinum To Synthesize Superconductors
Researchers have synthesized a superconducting material out of platinum, which was previously thought to be unsuitable for superconductivity.
Vibrating Tool Add-On Allows Surgeons To ‘Feel’ What They Can’t Touch
A small vibrating device added to surgical tools may help improve the ability of the surgeon to sense details and textures of a patient's internal organs and tissues.
A (Laser) Shocking Way To Predict How Earth-Type Planets Form
Using a technique called laser shock, researchers in Japan have provided insights into how Earth-type planets form when giant asteroids collide.
Astronomers Find Center Of The Milky Way is Devoid Of Young Stars
An international team of astronomers has found a huge region in the inner Milky Way where there is a strange absence of young stars.
microRNA-155 Key To Immune System ‘Tango’
Mimicking a key player in how immune cells 'dance' with each other to produce antibodies could help boost immune responses.
Our Immunity Decreases In Old Age Due To Lack Of Support
Immune cells called naïve T-cells start to disappear as we age, possibly due to deterioration in the environment that supports the survival of these cells, a study shows.
Stem Cell Therapy Marketing Rife In Rich Countries: Study
Advanced economies such as Singapore and Japan are home to stem cell clinics that engage in murky marketing practices, a study shows.
Takeda, TiGenix Announce Phase III Trial Results For Crohn’s Disease Drug
A significantly greater proportion of patients in the treatment group versus the placebo group achieved combined remission at week 24.